Management Strategies for Acute and Chronic Complications of Cystic Fibrosis
Pulmonary DiseaseAcute and Chronic Complications of Cystic Fibrosis
1 ANCC Contact Hours 1 AMA PRA Category 1 Credit(s) ™
October 27, 2015
The accreditation for this activity has expired.
Primary Audience:
Pulmonologists; physician assistants; nurse practitioners; and nurses involved in the management of patients with cystic fibrosis
Relevant Terms:
cystic fibrosis; chronic constipation; distal intestinal obstruction syndrome; chronic pain; osteoporosis; liver disease; hemoptysis; pneumothorax
Patrick A. Flume, MD, FCCP
Patrick A. Flume, MD, FCCP
Professor of Medicine and Pediatrics
Director, Adult Cystic Fibrosis Program
Medical University of South Carolina
Charleston, South Carolina
Bio
Dr. Patrick Flume joined the faculty of the Pulmonary and Critical Care Division at the Medical University of South Carolina in 1993. He is now a Professor of Medicine and Pediatrics, overseeing a rapidly growing Cystic Fibrosis Center. Though he continues to practice general pulmonary and critical care medicine, his primary interests are in CF and bronchiectasis, and chronic lung infections, including nontuberculous mycobacteria.The MUSC Cystic Fibrosis Center is the principal CF program in South Carolina. They provide state-of-the-art care to patients and families with CF; provide primary educator of clinicians and basic scientists in the field of CF; and perform basic and clinical research in the field of CF. Dr. Flume is the MUSC CF Center Director and has national recognition by the national and international CF community having served on the Cystic Fibrosis Foundation Center Committee, the Adult Care Consensus Committee, the Advisory Task Force on Adult Issues, the Professional Education Committee, and as co-chair for the Pulmonary Practice Guidelines Committee.
Susan L. Gray, RN, MSN
Susan L. Gray, RN, MSN
Adult CF & NTM Nurse Coordinator
Medical University of South Carolina
Charleston, South Carolina
Bio
Susan L. Gray, RN, MSN is a Registered Nurse with over 25 years of nursing experience; she has served as the Adult CF program coordinator at the Medical University of South Carolina since 1998. Ms Gray has served as a mentor for the CF Foundation coordinator apprenticeship program and is recognized as a key opinion leader in the field of the adult with cystic fibrosis. Ms Gray has a keen interest in adherence and access challenges and has presented throughout the US on these topics. Though her primary interest is in CF, Ms. Gray has expanded her coordinator role to include the nontuberculous mycobacteria patient.| 1. | Recognize complications and disorders that are common among patients with CF | 2. | Identify effective strategies for short-term management of acute complications |
| 3. | Describe effective long-term strategies for managing chronic complications |
| 1. | Recognize complications and disorders that are common among patients with CF |
| 2. | Identify effective strategies for short-term management of acute complications |
| 3. | Describe effective long-term strategies for managing chronic complications |
PROGRAM AGENDA
Program Overview - 5 minutes
CME/CE Online Activity - 40 minutes
Self-Assessment Questions - 10 minutes
Course Evaluation and Application for CME/CE Credit - 5 minutes
This activity is jointly provided by:
in partnership with:
This activity is supported by an educational grant from Vertex Pharmaceuticals Incorporated.
Statement of Need/Program Overview
Cystic fibrosis (CF) is a life-limiting autosomal recessive disease affecting more than 70,000 people worldwide and 30,000 in the United States and is more common among white individuals of Northern European ancestry. Earlier diagnosis, treatment of exacerbations, and use of long-term therapies have all increased the lifespan of patients with CF. The median survival age of patients with CF has increased from 5 years in 1955 to 41.1 years in 2012. As life expectancy for patients with CF continues to increase with newer and more effective therapies, there has been an increasing number of reported CF-related complications. Clinicians need more education on how to manage CF-related issues, some chronic and some acute, on an ongoing basis.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Global Academy of Medical Education. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's COA.
This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hours of Category 1 credit for completing this program.
Term of Offering
This activity was released on October 27, 2015 and is valid for one year. Requests for credit must be made no later than October 27, 2016.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com.
Instructions for Obtaining Credit
In order to receive credit, participants must review the online activity in its entirety, including the learning objectives, statement of need, and interactive portion. Statements of credit will be immediately available upon completion of the online evaluation form and posttest, participants must score at least a 70%.
Fee Information& Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Faculty or Presenter | Reported Financial Relationship |
| Patrick A. Flume, MD | Grant Support from: Bayer Healthcare AG; Cystic Fibrosis Foundation; Gilead Sciences, Inc, Hill-Rom Services; Insmed KaloBios; N30 Pharmaceuticals, Inc; National Institutes of Health; Novartis; Pharmaxis Limited; Savara Pharma; Vertex Pharmaceuticals, Inc Consultant for: Enanta; Gilead; Insmed; Vertex Pharmaceuticals, Inc, Novartis; Pharmaxis Limited; Savara Pharma |
| Susan L. Gray, RN, MSN | Nothing to disclose. |
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Planner or Manager | Reported Financial Relationship |
| Ashley Marostica, RN, MSN | Nothing to disclose |
| Amanda Glazar, PhD | Nothing to disclose |
| Andrea Funk | Nothing to disclose |
| Laura Gilsdorf | Nothing to disclose |
| Mike LoPresti | Nothing to disclose |
| Josh Kilbridge | Nothing to disclose |
| Shirley V. Jones, MBA | Nothing to disclose |
| Sylvia H. Reitman, MBA, DipEd | Nothing to disclose |
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Global Academy of Medical Education do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6+ for Mac OSX 10.7 and above For video playback, install the latest version of Flash or Quicktime. |
